Evaxion Biotech (EVAX) Tops Q3 EPS by 3c

Evaxion Biotech (NASDAQ: EVAX) reported Q3 EPS of ($0.24), $0.03 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.

You May Also Be Interested In

• Evaxion adds brain cancer vaccine program, drops EVX-03
• The LGL Group (LGL) Misses Q2 EPS by 8c
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24